DEPARTMENT OF DEFENSE - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS

Synopsis of Open Program Funding Opportunities



FY22 Defense Medical Research and Development Program (DMRDP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Battlefield Wound Management and Infection Research (BWMIR) Award Extramural:
Targeted Broad Agency Announcement
Submission Instructions

Intramural:
Program Announcement
September 21, 2022 Funding Level 1:
  • Maximum funding of $1,200,000 for total costs (to include direct and indirect costs).
  • Maximum period of performance is 3 years.
Funding Level 2:
  • Maximum funding of $2,200,000 for total costs (to include direct and indirect costs).
  • Maximum period of performance is 4 years.
Pre-Application (Letter of Intent):
October 20, 2022 5:00 p.m. Eastern Time

Application:
November 16, 2022 11:59 p.m. Eastern Time

FY22 Kidney Cancer Research Program (KCRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Academy of Kidney Cancer Investigators – Early-Career Scholar Award (AKCIECSA) Program Announcement
Application Instructions
June 16, 2022
  • Maximum funding of $725,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 4 years.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
Pre-Application (Letter of Intent):
September 29, 2022
5:00 p.m. Eastern Time

Application:
October 20, 2022
11:59 p.m. Eastern Time
Nurse-Initiated Research Award (NIRA) Program Announcement
Application Instructions
June 16, 2022
  • Maximum funding of $300,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 2 years.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
Pre-Application (Letter of Intent):
September 29, 2022
5:00 p.m. Eastern Time

Application:
October 20, 2022
11:59 p.m. Eastern Time
Clinical Trial Award (CTA) Program Announcement
Application Instructions
June 16, 2022
  • Maximum funding of $1,500,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 4 years.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
Cell Therapy Focus Option:
  • Maximum funding of $2,000,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 4 years.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
Pre-Application (Letter of Intent):
September 29, 2022
5:00 p.m. Eastern Time

Application:
October 20, 2022
11:59 p.m. Eastern Time

FY22 Peer Reviewed Cancer Research Program (PRCRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Behavioral Health Science Award (BHSA) II Program Announcement
Application Instructions
August 4, 2022
  • The maximum allowable funding for the entire period of performance is $1,000,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 4 years.
Pre-Application (Letter of Intent): September 28, 2022
5:00 p.m. Eastern Time

Application: October 20, 2022
11:59 p.m. Eastern Time
Career Development Award (CDA) – Scholar Option II Program Announcement
Application Instructions
August 4, 2022
  • Maximum funding for the entire period of performance is $800,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 4 years.
Pre-Application (Letter of Intent): September 28, 2022
5:00 p.m. Eastern Time

Application: October 20, 2022
11:59 p.m. Eastern Time

FY22 Reconstructive Transplant Research Program (RTRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Concept Award (CA) Program Announcement
Application Instructions
June 15, 2022
  • Maximum funding of $200,000 for total costs.
  • Maximum period of performance is 18 months.
Pre-Application (Letter of Intent):
September 28, 2022
5:00 p.m. ET

Application:
October 19, 2022
11:59 p.m. ET

FY22 Toxic Exposures Research Program (TERP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Investigator-Initiated Research Award (IIRA) Program Announcement
Application Instructions
September 21, 2022
  • The maximum allowable funding for the entire period of performance is $500,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 3 years.
Pre-Application (Letter of Intent):
November 3, 2022 5:00 p.m. Eastern Time (ET)

Letter of Intent is required; an invitation to submit full application is not required.

Application:
December 1, 2022 11:59 p.m. ET
Translational Research Award (TRA) Program Announcement
Application Instructions
September 21, 2022
  • The maximum allowable funding for the entire period of performance is $800,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 3 years.
Partnering PI Option:
  • The maximum allowable funding for the entire period of performance is $1,600,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 3 years.
Pre-Application (Letter of Intent):
November 3, 2022 5:00 p.m. Eastern Time (ET)

Letter of Intent is required; an invitation to submit full application is not required.

Application:
December 1, 2022 11:59 p.m. ET
Clinical Trial Award (CTA) Program Announcement
Application Instructions
September 21, 2022
  • The maximum allowable funding for the entire period of performance is $1,500,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 4 years.
Partnering PI Option:
  • The maximum allowable funding for the entire period of performance is $2,500,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 4 years.
Pre-Application (Letter of Intent):
November 3, 2022 5:00 p.m. Eastern Time (ET)

Letter of Intent is required; an invitation to submit full application is not required.

Application:
December 1, 2022 11:59 p.m. ET